Edition:
United States

Microbot Medical Inc (MBOT.OQ)

MBOT.OQ on NASDAQ Stock Exchange Capital Market

0.79USD
23 Apr 2018
Change (% chg)

$-0.01 (-0.73%)
Prev Close
$0.79
Open
$0.79
Day's High
$0.80
Day's Low
$0.79
Volume
20,576
Avg. Vol
78,240
52-wk High
$5.99
52-wk Low
$0.58

Latest Key Developments (Source: Significant Developments)

Microbot Medical Exercises Option To Buy Novel Technology From Cardiosert
Monday, 16 Apr 2018 04:01pm EDT 

April 16 (Reuters) - Microbot Medical Inc ::MICROBOT MEDICAL EXERCISES OPTION TO ACQUIRE NOVEL TECHNOLOGY FROM CARDIOSERT LTD..  Full Article

Microbot Medical Says ‍U.S. Patent And Trademark Office Issued A Notice Of Allowance Covering Company's Tipcat Technology Platform​
Thursday, 14 Dec 2017 07:00am EST 

Dec 14 (Reuters) - Microbot Medical Inc ::MICROBOT MEDICAL INC - ‍U.S. PATENT AND TRADEMARK OFFICE ISSUED A NOTICE OF ALLOWANCE COVERING COMPANY'S TIPCAT TECHNOLOGY PLATFORM​.  Full Article

Microbot Medical Q2 loss per share $0.12
Monday, 14 Aug 2017 04:01pm EDT 

Aug 14 (Reuters) - Microbot Medical Inc :Microbot Medical Inc reports second quarter 2017 financial results and recent development and strategic progress.Q2 loss per share $0.12.Microbot Medical Inc - ‍at June 30, 2017, company's cash and cash equivalents totaled approximately $13 million​.Microbot Medical Inc - ‍based on anticipated cash utilization, company believes it has sufficient resources through 2019​.  Full Article

Microbot Medical announces $10 mln registered direct offering of common stock
Monday, 5 Jun 2017 09:05am EDT 

June 5 (Reuters) - Microbot Medical Inc :Microbot Medical announces $10 million registered direct offering of common stock.Microbot Medical - entered into a securities purchase agreement with three institutional investors to purchase 3.75 million shares of common stock.Microbot Medical- expects to use resources from financing to expand, leverage current virob and tipcat technology platforms.  Full Article

Microbot Medical reports Q1 loss per share $0.04
Monday, 15 May 2017 07:30am EDT 

May 15 (Reuters) - Microbot Medical Inc :Reports first quarter 2017 financial results and recent development progress.Q1 loss per share $0.04.Microbot medical inc - research and development expenses for quarter ended march 31, 2017 were $0.184 million compared to $0.219 million.Microbot medical inc - at march 31, 2017, microbot medical had cash and cash equivalents of $5.0 million.Microbot medical inc - continues to believe it has resources to execute its development and fda submission plans.  Full Article

Microbot Medical's CEO reports 10.2 pct stake - SEC filing
Monday, 9 Jan 2017 07:07pm EST 

Microbot Medical Inc :Microbot Medical Inc 's CEO Harel Gadot reports 10.2 percent stake in Microbot Medical as of Nov 28, 2016 - sec filing.  Full Article

Microbot Medical's CEO reports 10.2 pct stake - SEC filing
Monday, 9 Jan 2017 04:44pm EST 

Microbot Medical Inc :Microbot Medical Inc 's CEO Harel Gadot reports 10.2 percent stake in Microbot Medical as of Nov 28, 2016 - sec filing.  Full Article

Yoseph Bornstein reports 14.63 pct stake in Microbot Medical as of Nov. 28 - SEC filing
Thursday, 8 Dec 2016 11:34am EST 

Yoseph Bornstein:Yoseph Bornstein reports 14.63 percent stake in Microbot Medical Inc as of Nov. 28 - SEC filing.  Full Article

StemCells and units entered into asset purchase agreement with Boco Silicon Valley on Nov. 11
Tuesday, 15 Nov 2016 04:46pm EST 

Stemcells Inc : On November 11, 2016 co & units entered into an asset purchase agreement with Boco Silicon Valley -sec filing . Stemcells-Sellers will sell to Boco US certain stem and progenitor cell lines that have been researched, studied or manufactured by company since 2007 .Stemcells- sellers will sell to Boco US certain stem, progenitor cell lines in exchange for $4 million in cash.  Full Article

Stemcells says respective boards of co and Microbot approved merger agreement
Monday, 15 Aug 2016 06:03pm EDT 

Stemcells Inc : Respective boards of directors of stemcells and microbot have approved merger agreement - sec filing . Following consummation of merger, former stockholders of microbot and certain advisors with respect to merger expected to own 95% of combined co . Following consummation of merger, current stockholders of microbot expected to own 5% of combined co . On august 15, 2016, co entered into an agreement and plan of merger and reorganization with microbot medical ltd . Co will seek to amend its certificate of incorporation to effect a reverse stock split of company's common stock, if necessary . Will seek to amend its certificate of incorporation to change name of co to 'microbot medical inc.' or another name designated by microbot .Merger agreement provides that board of directors of company will be designated by microbot.  Full Article

BRIEF-Microbot Medical Exercises Option To Buy Novel Technology From Cardiosert

* MICROBOT MEDICAL EXERCISES OPTION TO ACQUIRE NOVEL TECHNOLOGY FROM CARDIOSERT LTD. Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)